Indexé dans
- RechercheRef
- Université Hamdard
- EBSCO AZ
- Fondation genevoise pour la formation et la recherche médicales
- Pub européen
- Google Scholar
Liens utiles
Partager cette page
Dépliant de journal
Revues en libre accès
- Agriculture et aquaculture
- Alimentation et nutrition
- Biochimie
- Bioinformatique et biologie des systèmes
- Business & Management
- Chimie
- Génétique et biologie moléculaire
- Immunologie & Microbiologie
- Ingénierie
- La science des matériaux
- Neurosciences & Psychologie
- Science générale
- Sciences cliniques
- Sciences environnementales
- Sciences médicales
- Sciences pharmaceutiques
- Sciences vétérinaires
- Soins infirmiers et soins de santé
Abstrait
A Possible New Treatment Method for Age-Related Macular Degeneration: A Preliminary Study
Asim Kayiklik
Background: Age-related macular degeneration (AMD) is a disease that occurs in older ages and causes irreversible blindness. There is no curative treatment for AMD currently. The aim of this study is to investigate the efficacy of a new treatment method in AMD.
Methods: This was a prospective study. 14 patients with AMD were included to the study. We prepared a new solution including Coqun (0.5 cc) and PRP (platelet rich plasma, 1.5 cc). Totally, a 2 cc solution is obtained. The solution was injected into the subtenon space in the damaged eyes of patients once a week for three consecutive weeks. Before the treatment, first, second, and third month after the first application, Vo findings were noted and the data was compared statistically.
Results: Mean age of the patients was 65.4 ± 5.82 and 50% (N=7) of the patients were male. According to the preop period, first, second, and third month Vo values increased significantly (p<0.05). Vo values of the patients were found to be increased as the time progressed (p<0.05)
Conclusion: It can be speculated that this new method may be an effective treatment for AMD patients.